In April 2018, CIP VII signed an agreement with CDC Group, the UK government’s development finance institution, to commit up to $300m to pursue secondary opportunities in India-focused private equity funds. The transaction combines CDC’s deep knowledge of the Indian market with Coller Capital’s expertise in complex investments and innovative transaction structures. In May 2018 the partnership closed on its first transaction, the $98m GP-led secondary investment in a 2008-vintage India-focused fund.
Strategy: Private capital
Nordic Capital
In 2018, CIP VII led the world’s largest GP-led transaction of its time: a liquidity offer made for €2.2bn to Nordic Capital investors.
Aberdeen Private Equity Funds Ltd
In March 2018, CIP VII acquired 45 LP positions, totalling $350m, from Aberdeen Private Equity Funds Limited.
Shawbrook
In July 2017 CIP VII invested £125m into the public to private acquisition of Shawbrook Bank by Pollen Street Capital and BC Partners.
J C Flowers
In July 2016, CIP VI and CIP VII committed $288m to a GP-led transaction: a liquidity offer made to J C Flowers investors.
Irving Place Capital
In July 2015, CIP VI was the lead investor in a transaction, committing $645m, which allowed Irving Place Capital to reposition its 2006-vintage fund and establish a new investment vehicle.
Monte dei Paschi di Siena
In September 2014, CIP VI acquired a €175m funds & directs portfolio from a leading Italian bank, Monte dei Paschi di Siena.
American Capital
In May 2014, CIP VI was a leading member of an investor group which established American Capital’s third private equity fund, that consisted of seven companies from previous funds and capital for new investments.
ABSA
In December 2013, CIP VI was part of a syndicate which purchased the interests of Absa Capital Private Equity Funds I from Barclays Africa Group.
Lloyds Banking Group
In August 2012, CIP VI agreed to fund the acquisition of a $1.9bn private equity portfolio from Lloyds Banking Group.